Industry
Biotechnology
Companies applying molecular biology to develop therapeutics and diagnostics. High-risk/high-reward: valuations tie to clinical trial success, intellectual property and partnerships with big pharma.
Total Companies
1 448
1 382 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Abbvie Inc
ABBV
|
$249.78 |
-2.6%
|
$441.3B |
|
|
|
Amgen Inc
AMGN
|
$394.36 |
-9.8%
|
$212.8B |
|
|
|
Gilead Sciences Inc
GILD
|
$146.74 |
-2.8%
|
$182.2B |
|
|
|
Vertex Pharmaceuticals Inc
VRTX
|
$530.01 |
-2.9%
|
$134.5B |
|
|
|
Regeneron Pharmaceuticals Inc
REGN
|
$813.14 |
-1.8%
|
$85.2B |
|
|
|
argenx SE
ARGX
|
€865.8 |
-0.4%
|
$62.9B |
|
|
|
CSL Ltd
CSL
|
AU$174.8 |
+0.9%
|
$60.4B |
|
|
|
Moderna Inc
MRNA
|
$141.37 |
-2.9%
|
$56.1B |
|
|
|
Natera Inc
NTRA
|
$325.575 |
-0.8%
|
$46.6B |
1 377 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
